Pricing Log in Create free account

Cellectar Biosciences, Inc. (CLRB) vs CytoMed Therapeutics Limited (GDTC)

Cellectar Biosciences, Inc. and CytoMed Therapeutics Limited are both Biotechnology companies. Cellectar Biosciences, Inc. and CytoMed Therapeutics Limited are of similar size ($10.9M and $10.4M). Across the 9 metrics below, Cellectar Biosciences, Inc. leads on 5 and CytoMed Therapeutics Limited on 4.

Valuation

Metric CLRB GDTC Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.51 0.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.78 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (367.46%) (35.00%) (32.88%)
Free cash flow yield (127.83%) (0.42%) (23.13%)

Profitability

Metric CLRB GDTC Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (125.99%) 0.00% (51.96%)
Return on assets (88.70%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLRB GDTC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 80.07% (68.75%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLRB GDTC Biotechnology median
Debt to equity 0.00 80.30 0.00
Current ratio 6.66 2.64 4.97
Net debt to EBITDA 0.58 0.86 1.01

Dividend

Metric CLRB GDTC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLRB GDTC Biotechnology median
Market cap 10.87m 10.41m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack